Want to see SLAB full AI Analyst Report?
Top Page
Silicon Laboratories
(NASDAQ:SLAB)
Select Model
Select Model
Rating:57Neutral
Price Target:
$226.00
▲(4.21% Upside)
Action:Reiterated
Date:08/18/26
The score is driven primarily by solid financial resilience (zero debt and strong equity base) but held back by still-negative profitability and inconsistent free cash flow. Technical indicators are broadly neutral, providing limited confirmation of near-term momentum. Valuation metrics are weak due to losses (negative P/E) and no dividend yield, while the TI acquisition progress is a supportive but not fully de-risked corporate catalyst.
Positive Factors
Debt-free balance sheet
A debt-free balance sheet and substantial equity base provide financial flexibility, reduce refinancing risk, and help Silicon Labs fund product development or manage cyclical semiconductor demand without heavy leverage.
Negative Factors
Persistent operating losses
Negative operating and net income show that healthy gross margins have not yet translated into sustainable earnings. Continued losses could constrain internal investment capacity and indicate that the recovery remains incomplete.
Read all positive and negative factors
Positive Factors
Negative Factors
Debt-free balance sheet
A debt-free balance sheet and substantial equity base provide financial flexibility, reduce refinancing risk, and help Silicon Labs fund product development or manage cyclical semiconductor demand without heavy leverage.
Read all positive factors
Silicon Laboratories Key Performance Indicators (KPIs)
Any
Revenue by Sales Channel
Breaks down sales through direct OEM customers, distributors, and channel partners, helping gauge revenue stability and visibility. Reveals whether growth comes from broad market adoption (distributors) or a few large customers, and flags risks from channel inventory swings and margin differences tied to how products are sold.
Breaks down sales through direct OEM customers, distributors, and channel partners, helping gauge revenue stability and visibility. Reveals whether growth comes from broad market adoption (distributors) or a few large customers, and flags risks from channel inventory swings and margin differences tied to how products are sold.
Data provided by:
The Fly
The FlySilicon Laboratories (SLAB) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$7.31B
Dividend YieldN/A
Average Volume (3M)439.08K
Price to Earnings (P/E)―
Beta (1Y)1.30
Revenue Growth21.71%
EPS Growth63.22%
CountryUS
Employees1,930
SectorTechnology
Sector Strength88
IndustrySemiconductors
Share Statistics
EPS (TTM)-1.18
Shares Outstanding33,366,760
10 Day Avg. Volume294,127
30 Day Avg. Volume439,085
Financial Highlights & Ratios
PEG Ratio1.00
Price to Book (P/B)3.94
Price to Sales (P/S)5.50
P/FCF Ratio65.62
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$212.00Price Target Upside-2.25% Downside
Rating ConsensusHold
Number of Analyst Covering3
EPS Forecast (FY)2.92
Revenue Forecast (FY)$927.78M
Silicon Laboratories Business Overview & Revenue Model
Company Description
Silicon Laboratories Inc., a fabless semiconductor company, provides mixed-signal analog intensive products in the United States, China, Taiwan, and internationally. Its products are used in various electronic products in a range of applications f...
How the Company Makes Money
Silicon Labs makes money primarily by selling semiconductor products (integrated circuits) used to add wireless connectivity and embedded compute to customers’ end devices. Its core revenue stream is product revenue from shipments of wireless SoCs...
Silicon Laboratories Earnings Call Summary
Earnings Call Date:Nov 04, 2025
(Q3-2025)
| % Change Since: |
Next Earnings Date:Nov 04, 2026
Earnings Call Sentiment Positive
Silicon Labs reported strong revenue growth and improved gross margins, driven by strategic execution and innovation in IoT. However, some challenges remain with customer inventory levels and sustainable gross margins. Overall, the company's outlook remains positive with expectations for continued market share gains.Positive Updates
Strong Revenue Growth
Silicon Labs expects full-year revenue growth of 34% compared to 2024, with a diverse set of industrial applications driving a 7% sequential increase to $206 million in the September quarter.
Negative Updates
Onetime Benefit in Gross Margin
The December quarter includes an expected onetime benefit to gross margins, which adds approximately 200 basis points, indicating that current gross margins may not be sustainable long-term.
Read all updates
Q3-2025 Updates
Positive
Negative
Strong Revenue Growth
Silicon Labs expects full-year revenue growth of 34% compared to 2024, with a diverse set of industrial applications driving a 7% sequential increase to $206 million in the September quarter.
Read all positive updates
Company Guidance
In the Silicon Labs Third Quarter Fiscal 2025 Conference Call, the company provided robust guidance and an optimistic outlook based on their recent financial performance. For the full year, they anticipate a 34% revenue growth compared to 2024, driven by strong demand in industrial and commercial sectors and a significant uptick in smart meter and medical applications. In Q3, revenue reached $206 million, a 7% sequential increase, and a 24% rise year-over-year. They project Q4 revenue between $200 million and $215 million, with gross margins expected to expand to 62%-64%. This margin increase incorporates a one-time benefit contributing about 200 basis points. Additionally, the company forecasted a non-GAAP operating expense range of $110 million to $112 million and anticipated non-GAAP earnings per share of $0.40 to $0.70. They highlighted strategic innovations like the Studio 6 enablement platform and Simplicity AI SDK, which are expected to accelerate IoT market penetration and drive long-term growth.Silicon Laboratories Financial Statement Overview
Summary
Income Statement
44
Neutral
Balance Sheet
78
Positive
Cash Flow
52
Neutral
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 855.89M | 784.76M | 584.39M | 782.26M | 1.02B | 720.86M |
| Gross Profit | 512.72M | 456.98M | 312.19M | 460.59M | 642.56M | 425.39M |
| EBITDA | 10.23M | -18.85M | -104.92M | 46.09M | 189.77M | 35.41M |
| Net Income | -39.11M | -64.91M | -191.01M | -34.52M | 91.40M | 2.12B |
Balance Sheet | ||||||
| Total Assets | 1.25B | 1.27B | 1.22B | 1.44B | 2.17B | 2.96B |
| Cash, Cash Equivalents and Short-Term Investments | 397.24M | 443.62M | 382.16M | 439.22M | 1.19B | 2.04B |
| Total Debt | 0.00 | 0.00 | 21.43M | 64.83M | 547.58M | 450.60M |
| Total Liabilities | 158.25M | 174.90M | 142.65M | 234.37M | 764.42M | 745.87M |
| Stockholders Equity | 1.09B | 1.09B | 1.08B | 1.21B | 1.41B | 2.21B |
Cash Flow | ||||||
| Free Cash Flow | -5.43M | 65.79M | -25.66M | -52.63M | 45.28M | -129.02M |
| Operating Cash Flow | 33.09M | 95.71M | -13.91M | -30.35M | 71.81M | -100.44M |
| Investing Cash Flow | 29.26M | -12.03M | 113.12M | 469.81M | 240.54M | 2.27B |
| Financing Cash Flow | -14.63M | -1.07M | -45.10M | -711.87M | -887.05M | -1.30B |
Silicon Laboratories Technical Analysis
Positive
216.88
Price Trends
218.30
Positive
216.48
Positive
188.08
Positive
Market Momentum
0.29
Negative
56.77
Neutral
57.22
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SLAB, the sentiment is Positive. The current price of 216.88 is below the 20-day moving average (MA) of 217.99, below the 50-day MA of 218.30, and above the 200-day MA of 188.08, indicating a bullish trend. The MACD of 0.29 indicates Negative momentum. The RSI at 56.77 is Neutral, neither overbought nor oversold. The STOCH value of 57.22 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SLAB.
Silicon Laboratories Risk Analysis
Silicon Laboratories disclosed 42 risk factors in its most recent earnings report. Silicon Laboratories reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Silicon Laboratories Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | $15.48B | 111.34 | 6.50% | ― | 8.08% | -33.87% | |
70 Outperform | $5.86B | 13.97 | 20.35% | ― | 6.25% | 27.52% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | $13.63B | 22.72 | 12.37% | 0.51% | 17.93% | 82.27% | |
61 Neutral | $12.60B | -336.45 | -5.93% | ― | 14.22% | 81.01% | |
60 Neutral | $7.34B | 473.46 | 1.48% | ― | 24.22% | ― | |
57 Neutral | $7.31B | -185.29 | -3.59% | ― | 21.71% | 63.22% |
* Technology Sector Average
SLAB
Silicon Laboratories
218.92
85.16
63.67%
AMKR
Amkor
50.89
28.09
123.16%
CRUS
Cirrus Logic
118.07
5.25
4.65%
ONTO
Onto Innovation
299.50
193.57
182.73%
SMTC
Semtech
125.36
76.89
158.63%
ALGM
Allegro MicroSystems
38.35
7.87
25.82%
Silicon Laboratories Corporate Events
M&A TransactionsRegulatory Filings and Compliance
Silicon Laboratories Merger with Texas Instruments Gains Approval
Positive
May 26, 2026
On February 4, 2026, Silicon Laboratories Inc. agreed to be acquired by Texas Instruments Incorporated through a merger in which a wholly owned Texas Instruments subsidiary will merge into Silicon Labs, leaving Silicon Labs as a wholly owned subsi...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.